Showing 1–12 of 14 resultsSorted by popularity
-
$0.47 - $7.00
In Vivo Safety and Efficacy Platform for Immunotherapies
LT0209, tech sheet
-
$0.34 - $3.00
Advantages of Evaluating Immunomodulatory Therapeutics In Vivo in Hu-PBMC NSG Mice to Investigate GVHD
LT0034, Case Study
-
$0.47 - $7.00
In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety
Letter Size Bifold 8.5 x 11 Click to View and Download PDF -
$0.81 - $9.00
A New MHC Class I & II Deficient Platform Humanized With PBMC Has Delayed Xenogeneic GvHD
Fold & Staple Booklet 8.5 x 11 Click to View and Download PDF